CPHI vs UPST · rev $4.1M vs P/E 74, rev $636.5M
China Pharma Holdings Inc (CPHI) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported UPST revenue for 2024-12-31 was $636.5M. Net income was -$128.6M. Revenue was up 23.9% from 2023-12-31 to 2024-12-31. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
CPHI currently screens at market cap $29.0M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the CPHI and UPST stock pages for the full models.
Not investment advice.